在现代系统性治疗时代,用于大脑转移的低剂量放射外科手术
Juan Diego Alzate1, Elad Mashiach1, Assaf Berger1
1Department of Neurological Surgery, NYU Langone Health, New York University, New York , New York , USA.
Neurosurgery
|June 16, 2023
概括
针对大脑转移 (BMs) 的低剂量立体射线手术 (SRS) 可以实现良好的局部控制 (LC) 和低毒性. 瘤体积,黑色素瘤组织学和边缘剂量是用SRS治疗的BM中局部衰竭 (LF) 的关键预测因素.
科学领域:
- 神经外科 神经外科
- 辐射瘤学 辐射瘤学
- 医学瘤学 医学瘤学
背景情况:
- 对于大脑转移 (BMs) 的立体射线外科手术 (SRS) 传统上使用剂量减少用于较大的瘤或先前照射.
- 降低剂量历来导致了低于最佳的局部控制 (LC).
- 现代的全身疗法可以在选择的BM中允许有效的低剂量SRS.
研究的目的:
- 评估局部控制 (LC) 和低剂量SRS对BMs的毒性.
- 在用低剂量SRS.治疗的BM中确定局部衰竭 (LF) 的预测因子.
- 在当代全身疗法背景下评估低剂量SRS的可行性.
主要方法:
- 在2014年至2021年期间,对102名患者进行了回顾性审查,其中包括688名BM患者.
- 低边际剂量SRS定义为≤14 Gy.
- 瘤控制与人口统计,临床和剂量计数据的相关性.
主要成果:
- 最常见的原发性癌症是肺癌 (47.1%) 和乳腺癌 (30.4%).
- 中位瘤体积为0.037cc,中位值剂量为14 Gy.
- 一年和两年的局部衰竭 (LF) 累计发病率分别为6%和12%.
- 较大的体积,黑色素瘤组织学和边缘剂量预测了LF.
- 一年和两年累计发生的不良辐射效应 (ARE) 是0.8%和2%.
结论:
- 低剂量SRS是一种可行的方法,可以在BM中实现可接受的LC.
- 瘤体积,黑色素瘤组织学和边缘剂量是LF的显著预测因素.
- 低剂量SRS可能对许多小瘤或邻近瘤,先前辐射或关键位置的瘤患者有价值,旨在维护LC和神经功能.
相关概念视频
Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Psychosurgery
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...


